Sofie Biosciences Completes Acquisition Of ZevacorPharma

Culver City-based Sofie Biosciences says it has completed its acquisition of Zevacor Pharma, and has rebranded itself as SOFIE, according to the company. Sofie is a developer of molecular imaging tools, used in PET imaging and radiosynthesis of PET compounds. Zevacor operates 16 radiopharmacies and provides contract manufacturing services.